Ascendis Pharma (ASND) Reports Q2 Loss of EUR0.55/Share
Ascendis Pharma (NASDAQ: ASND) reported Q2 EPS of (EUR0.55), versus (EUR0.94) reported last year.
For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.
Ascendis Pharma (NASDAQ: ASND) reported Q2 EPS of (EUR0.55), versus (EUR0.94) reported last year.
For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.